-
From Early Pharmacology to Recent Pharmacology Interventions in Acute Coronary SyndromesSzummer K, Jernberg T, Wallentin L. -
Diagnosis and Prognosis of Coronary Artery Disease with SPECT and PETAl Badarin FJ, Malhotra S.
-
Clinical Efficacy and Safety of Alirocumab after Acute Coronary Syndrome According to Achieved Level of Low-Density Lipoprotein Cholesterol: A Propensity Score-Matched Analysis of the ODYSSEY OUTCOMES TrialGG Schwartz, PG Steg, ODYSSEY OUTCOMES Committees and Investigators et al.
-
Optimal Timing of Intervention in NSTE-ACS Without Pre-Treatment The EARLY Randomized TrialG Lemesle, M Laine, M Pankert et al.
-
Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry dataGA Figtree, ST Vernon, N Hadziosmanovic et al.
-
Morphine and Cardiovascular Outcomes Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary AngiographyRHM Furtado, JC Nicolau, JP Guo et al.
-
Another Nail in the Coffin for Intra-Aortic Balloon Counterpulsion in Acute Myocardial Infarction With Cardiogenic ShockKatz SD, Smilowitz NR, Hochman JS.
-
Prevalence of Coronary Vasospasm Using Coronary Reactivity Testing in Patients With Spontaneous Coronary Artery DissectionSolaru KW, Heupler F, Kim ESH et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
